Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Corvus Pharmaceuticals (NASDAQ:CRVS) through any online brokerage.
Other companies in Corvus Pharmaceuticals’s space includes: Precigen Inc (NASDAQ:PGEN), MoonLake Immunotherapeutics (NASDAQ:MLTX), Immatics NV (NASDAQ:IMTX), Pharming Group (NASDAQ:PHAR) and MapLight Therapeutics Inc (NASDAQ:MPLT).
Corvus Pharmaceuticals has a consensus price target of $25.69.
The stock price for Corvus Pharmaceuticals (NASDAQ: CRVS) is $16.07 last updated April 24, 2026 at 9:30 AM EDT.
There are no upcoming dividends for Corvus Pharmaceuticals.
Corvus Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Corvus Pharmaceuticals.
Corvus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.